ArticleIEEE journal of translational engineering in health and medicine2025
Effective Tumor Annotation for Automated Diagnosis of Liver Cancer.
Article in IEEE journal of translational engineering in health and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Systematic Review of Deep Learning Approaches for Hepatopancreatic Tumor Segmentation.Journal of imaging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, visual cancer information retrieval using Artificial Intelligence has been shown to be effective in diagnosis and treatment. Especially for a modern liver-cancer diagnosis system, the automated tumor annotation plays a crucial role. So-called tumor annotation refers to tagging the tumor in Biomedical images by computer vision technologies such as Deep Learning. After annotation, the tumor information such as tumor location, tumor size and tumor characteristics can be output into a clinical report. To this end, this paper proposes an effective approach that includes tumor segmentation, tumor location, tumor measuring, and tumor recognition to achieve high-quality tumor annotation, thereby assisting radiologists in efficiently making accurate diagnosis reports. For tumor segmentation, a Multi-Residual Attention Unet is proposed to alleviate problems of vanishing gradient and information diversity. For tumor location, an effective Multi-SeResUnet is proposed to partition the liver into 8 couinaud segments. Based on the partitioned segments, the tumor is located accurately. For tumor recognition, an effective multi-labeling classifier is used to recognize the tumor characteristics by the visual tumor features. For tumor measuring, a regression model is proposed to measure the tumor size. To reveal the effectiveness of individual methods, each method was evaluated on real datasets. The experimental results reveal that the proposed methods are more promising than the state-of-the-art methods in tumor segmentation, tumor measuring, tumor localization and tumor recognition. Specifically, the average tumor size error and the annotation accuracy are 0.432 cm and 91.6%, respectively, which suggest potential for reducing radiologists' workload. In summary, this paper proposes an effective tumor annotation for an automated diagnosis support system. Clinical and Translational Impact Statement-The proposed methods have been evaluated and shown to significantly improve the efficiency and accuracy of liver tumor annotation, reducing the time required for radiologists to complete reports on tumor segmentation, liver partition, tumor measuring and tumor recognition. By integrating into existing clinical decision support systems, it has the potential to reduce diagnostic errors and treatment delays, thereby improving patient outcomes and clinical workflow.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.